Dr. Miele Cosmed Group S.A. produces and sells chemical and cosmetic assortments in Poland and internationally. It offers washing and care cosmetics, wet wipes, and laundry detergents for children; cleansing cosmetics, such as sanitizing gels and sprays, and liquid soaps; shower gels; and toilet cleaners, toilet blocks, and drain opener granules and gels; washing liquids and fabric softening concentrates; cleaning agents for kitchens and bathrooms; and hand sanitizing and surface disinfectants. The company markets its products primarily under the Bobini, Apart, Biophen, Mole, Sofin, Izo, and Izozid brands. The company was formerly known as Global Cosmed S.A. and changed its name to Dr. Miele Cosmed Group S.A. in March 2024. The company was founded in 1990 and is based in Radom, Poland.…
Dr. Miele Cosmed Group: spadek zysku netto o 70 proc. po trzech kwartałach 2026 roku
Dr. Miele Cosmed Group (WSE: DMG) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Household & Personal Products industry, part of the Consumer Defensive sector, and reports about 582 employees.
The shares were at 1.790 PLN on 20 November 2026, down 43.9% over 52 weeks. Its 52-week range is 1.680 PLN to 3.200 PLN: the price is 44.1% below the high and 6.5% above the low.
At a market capitalisation of 153.54M PLN, it trades at 11.9 times trailing earnings. The median trailing P/E of its 20 largest Household & Personal Products peers is 18.8, a discount of 36% for DMG.
Dr. Miele Cosmed Group reports return on equity of 7.3%, an operating margin of 3.6% and revenue down 2.6% year over year.
Its debt exceeds its cash by 59.35M PLN, a debt-to-equity ratio of 0.23. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.
No upcoming events tracked.